INS and metabolic dysfunction-associated steatotic liver disease: Individuals with excess hepatic fat or NAFLD are therefore unable to suppress hepatic gluconeogenesis normally in response to insulin, and the continued excessive hepatic glucose production contributes to hyperglycaemia and development of diabetes.